J&J halted the vaccine trails after some participant fell ill on Monday
Washington, United States: COVID-19 has swallowed the globe by its effects and death rates. Almost every corner of the earth is trying their best to deliver the vaccine for the deadly pandemic virus. Meanwhile one of the biggest American Multinational company Johnson and Johnson has temporarily halted the vaccine trial on Monday 13th October as the participants fell ill.
COVID-19 cases are increasing day by day with almost 38,053,748 cases and 1,085,558 deaths. The vaccine trails are going throughout the world.
Johnson and Johnson are known to deliver the best medical devices, pharmaceutical, and consumer packaged goods in every part of the globe.
According to the statement by the officials of J&J, they said1,085,558 that "We have temporarily halted further dosing in all our Covid-19 vaccine candidate clinical trials, including the Phase 3 ENSEMBLE trial, due to an unexplained illness in a study participant."
According to sources, a woman developed severe neurological symptoms consistent with transverse myelitis, a rare inflammation of the spinal cord. The study is the cause behind the pause.
The halt of the vaccine means the online registration system has been closed for the 60,000-patient clinical trial while the independent patient safety committee is summoned.
The American the multinational company had Started the Phase 3 trial recruiting participants in late September, intending to enrol up to 60,000 volunteers across more than 200 sites in the US and around the world.
Other countries like Argentina, Brazil, Chile, Colombia, Mexico, Peru and South Africa the trails are COVID-19 Vaccines are going on.
The Brief. Sign up to receive the top stories you need to know right now.